MKI67 and non-small cell lung carcinoma: Altogether, these results demonstrate that proliferating Ki-67+ IIC; CD3+, CD8+, and CD4+ TILs; CD20+ TIL-Bs; and HLA-DR and IFN-γ are positive prognostic markers for NSCLC patients.